First Time View on Human Metabolome Changes after a Single Intake of 3,4-Methylenedioxymethamphetamine in Healthy Placebo-Controlled Subjects-Reference-Cited by-同舟云学术

First Time View on Human Metabolome Changes after a Single Intake of 3,4-Methylenedioxymethamphetamine in Healthy Placebo-Controlled Subjects

Published:2017-08-09 Issue:9 Volume:16 Page:3310-3320
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Boxler Martina I.¹,Liechti Matthias E.²,Schmid Yasmin²,Kraemer Thomas¹,Steuer Andrea E.¹^ORCID

Affiliation:

1. Department of Forensic Pharmacology & Toxicology, Zurich Institute of Forensic Medicine, University of Zurich,Winterthurerstrasse 190/52, 8057 Zurich, Switzerland

2. Psychopharmacology Research, Division of Clinical Pharmacology and Toxicology, Department of Biomedicine, Department of Clinical Research, University Hospital Basel, 4031 Basel, Switzerland

Funder

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

American Chemical Society (ACS)

Subject

General Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jproteome.7b00294

Reference52 articles.

1. Duloxetine Inhibits Effects of MDMA (“Ecstasy") In Vitro and in Humans in a Randomized Placebo-Controlled Laboratory Study

2. Pharmacological characterization of designer cathinonesin vitro

3. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment